Analyze Diet

Induction of cytochrome P450 enzymes in primary equine hepatocyte culture.

Abstract: In this study, we established cell culture conditions for primary equine hepatocytes allowing cytochrome P450 enzyme (CYP) induction experiments. Hepatocytes were isolated after a modified method of Bakala et al. (2003) and cultivated on collagen I coated plates. Three different media were compared for their influence on morphology, viability and CYP activity of the hepatocytes. CYP activity was evaluated with the fluorescent substrate 7-benzyloxy-4-trifluoromethylcoumarin. Induction experiments were carried out with rifampicin, dexamethasone or phenobarbital. Concentration-response curves for induction with rifampicin were created. Williams' medium E showed the best results on morphology and viability of the hepatocytes and was therefore used for the following induction experiments. Cells cultured in Dulbecco's Modified Eagle Medium were not inducible. Incubation with rifampicin increased the CYP activity in two different hepatocyte preparations in a dose dependent manner (EC₅₀=1.20 μM and 6.06 μM; Emax=4.1- and 3.4-fold induction). No increase in CYP activity was detected after incubation with dexamethasone or phenobarbital. The hepatocyte culture conditions established in this study proved to be valuable for investigation of the induction of equine CYPs. In further studies, other equine drugs can be evaluated for CYP induction with this in vitro system.
Publication Date: 2013-08-01 PubMed ID: 23916975DOI: 10.1016/j.tiv.2013.07.009Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper examines the establishment of cell culture conditions for equine hepatocytes to allow the induction experiments of cytochrome P450 enzyme (CYP). It goes on to indicate that the best medium for hepatocytes morphology and viability was Williams’ medium E. The work also explores how the drug rifampicin increases CYP activity in the cells cultivated within this medium, providing a platform to further evaluate potential CYP induction with other equine drugs.

Methodology

  • Hepatocytes, which are liver cells, were initially isolated through a modified method from a previous study (Bakala et al., 2003). A process that involves the separation of liver cells for individual study.
  • These isolated cells were then cultivated. They were grown in a controlled environment on collagen I coated plates, which provide a conducive substrate for cell growth.
  • Three different media (biological substances necessary for maintaining living cells) were used in the experiment. These were assessed for the impact they had on the hepatocytes’ morphology (structure), viability (ability to live and grow), and their CYP activity – the activity of a specific family of enzymes.
  • The activity of CYP was evaluated using the fluorescent substrate 7-benzyloxy-4-trifluoromethylcoumarin – a compound that fluoresces, making it easier to observe and measure enzymatic activity.

Induction Experiments

  • Rifampicin, dexamethasone, and phenobarbital were used for induction experiments. These drugs are used to attempt to induce or stimulate the activity of CYP within the hepatocytes.
  • Additionally, concentration-response curves were created for rifampicin. These curves represent the relationship between the concentration of rifampicin and the response of the hepatocytes in terms of CYP activity.

Findings

  • From the three different media tested, Williams’ medium E was found to be the most effective. It had the most positive impact on the morphology and viability of the hepatocytes and was therefore selected for further induction experiments.
  • Cells that were cultivated in Dulbecco’s Modified Eagle Medium did not show a measurable response – they were not inducible.
  • Incubation with rifampicin markedly increased CYP activity in two different hepatocyte preparations, indicating a positive reaction between the two in a dose-dependent manner.
  • There was no detectable increase in CYP activity when hepatocytes were incubated with dexamethasone or phenobarbital.

Conclusion and Future Study

  • The hepatocyte culture conditions developed in the study proved effective for investigating the induction of the equine variant of CYP.
  • The study’s findings set the stage for future research, offering an in-vitro system where other equine drugs can be tested for their potential to induce CYP activity.

Cite This Article

APA
Stefanski A, Mevissen M, Möller AM, Kuehni-Boghenbor K, Schmitz A. (2013). Induction of cytochrome P450 enzymes in primary equine hepatocyte culture. Toxicol In Vitro, 27(7), 2023-2030. https://doi.org/10.1016/j.tiv.2013.07.009

Publication

ISSN: 1879-3177
NlmUniqueID: 8712158
Country: England
Language: English
Volume: 27
Issue: 7
Pages: 2023-2030
PII: S0887-2333(13)00187-2

Researcher Affiliations

Stefanski, A
  • Vetsuisse Faculty University of Bern, Division of Veterinary Pharmacology and Toxicology, Laenggassstrasse 124, CH-3012 Bern, Switzerland. Electronic address: anja.stefanski@vetsuisse.unibe.ch.
Mevissen, M
    Möller, A-M
      Kuehni-Boghenbor, K
        Schmitz, A

          MeSH Terms

          • Animals
          • Anti-Inflammatory Agents / adverse effects
          • Anti-Inflammatory Agents / pharmacology
          • Antibiotics, Antitubercular / adverse effects
          • Antibiotics, Antitubercular / pharmacology
          • Cell Survival / drug effects
          • Cells, Cultured
          • Coumarins / metabolism
          • Culture Media, Serum-Free / metabolism
          • Cytochrome P-450 Enzyme System / biosynthesis
          • Cytochrome P-450 Enzyme System / drug effects
          • Cytochrome P-450 Enzyme System / metabolism
          • Dexamethasone / adverse effects
          • Dexamethasone / pharmacology
          • Drug Evaluation, Preclinical / veterinary
          • Enzyme Induction / drug effects
          • Hepatocytes / cytology
          • Hepatocytes / drug effects
          • Hepatocytes / metabolism
          • Horses
          • Hypnotics and Sedatives / adverse effects
          • Hypnotics and Sedatives / pharmacology
          • Immunohistochemistry / veterinary
          • Indicators and Reagents / metabolism
          • Kinetics
          • Phenobarbital / adverse effects
          • Phenobarbital / pharmacology
          • Rifampin / adverse effects
          • Rifampin / pharmacology
          • Veterinary Drugs / adverse effects
          • Veterinary Drugs / pharmacology

          Citations

          This article has been cited 4 times.
          1. Testroet ED, Choudhary S, Choudhary RK, Beitz DC, Du M. Tumor necrosis factor alpha and palmitate simulate bovine fatty liver disease in vitro when using abattoir-derived primary bovine hepatocytes isolated by a novel nonperfusion method.. JDS Commun 2022 Nov;3(6):456-461.
            doi: 10.3168/jdsc.2022-0263pubmed: 36465509google scholar: lookup
          2. Cantiello M, Carletti M, Giantin M, Gardini G, Capolongo F, Cascio P, Pauletto M, Girolami F, Dacasto M, Nebbia C. Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.. Int J Mol Sci 2022 Mar 24;23(7).
            doi: 10.3390/ijms23073564pubmed: 35408925google scholar: lookup
          3. Ehrhardt S, Schmicke M. Isolation and cultivation of adult primary bovine hepatocytes from abattoir derived liver.. EXCLI J 2016;15:858-866.
            doi: 10.17179/excli2016-794pubmed: 28275320google scholar: lookup
          4. Shibany KA, Tötemeyer S, Pratt SL, Paine SW. Equine hepatocytes: isolation, cryopreservation, and applications to in vitro drug metabolism studies.. Pharmacol Res Perspect 2016 Oct;4(5):e00268.
            doi: 10.1002/prp2.268pubmed: 27713829google scholar: lookup